Differences in management and outcome of ischemic and non-ischemic cardiomyopathy
Authors:
- Andrew Paul SindoneASAndrew Paul Sindone
- Helen Siu Ping WongHWHelen Siu Ping Wong
- Saul Benedict FreedmanSFSaul Benedict Freedman
- 1 September 2008
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 129 (2) , 198-204
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)European Heart Journal, 2005
- Advances in the Management of Acute and Chronic Decompensated Heart FailureLippincott's Case Management, 2004
- Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic statusJACC, 2003
- Long-Term Trends in the Incidence of and Survival with Heart FailureNew England Journal of Medicine, 2002
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based studyThe Lancet, 2001
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Coronary artery disease as the cause of incident heart failure in the populationEuropean Heart Journal, 2001
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.Circulation, 1994